SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-216156
Filing Date
2022-08-09
Accepted
2022-08-09 16:12:10
Documents
14
Period of Report
2022-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d382521d8k.htm   iXBRL 8-K 24308
2 EX-99.1 d382521dex991.htm EX-99.1 198800
6 GRAPHIC g382521org001.jpg GRAPHIC 5140
  Complete submission text file 0001193125-22-216156.txt   366971

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA orgo-20220809.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20220809_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20220809_pre.xml EX-101.PRE 10817
8 EXTRACTED XBRL INSTANCE DOCUMENT d382521d8k_htm.xml XML 3270
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 221148428
SIC: 2834 Pharmaceutical Preparations